News
Nicole A. Cipriani, explores the clinical relevance of the BRAF p.V600E mutation in papillary thyroid carcinoma and its potential role in guiding treatment decisions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback